The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has already approved the Pfizer coronavirus vaccine (BNT162b2), with doses being delivered around that country starting today. On Thursday of this week, the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) will review the data and vaccination with the Pfizer vaccine could begin in the U.S. as early as Friday.
This report for professionals by the UK’s MHRA gives more insight into what we know so far.
childrenshealthdefense.org